Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of an investigational iNTS-TCV vaccine for invasive nontyphoidal Salmonella and typhoid fever
PACTR202306838192573Phase 2Recruiting
- Sponsor
- GSK
- Start
- Sep 2022
- Modality
- Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 2 trial of iNTS-TCV and iNTS-GMMA vaccine in nontyphoidal salmonellosis and typhoid fever (9 arms), sponsored by GSK. Started Sep 2022; status: recruiting.
02
Drugs
iNTS-TCViNTS-GMMA vaccine
03
Conditions
nontyphoidal salmonellosistyphoid fever
Beyond the preview
Go deeper on PACTR202306838192573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202306838192573.